MedTrace Logo

Implications of Appropriate Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD)

NCT04042168 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2022-08-30

No results posted yet for this study

Summary

Using various types of inhalers is the treatment cornerstone for COPD patients to control their symptoms. Many inhaler devices require minimum inspiratory effort to activate the device, COPD patients commonly use such devices. Those devices deliver the medications only when the patient forcefully inhales so the drug can reach the lungs, thus exerting their therapeutic action. The effect of appropriate use of the inhalers in patients with COPD is not well studied, and the impact of demonstrating that a patient can inhale forcefully enough to activate a device on its' effect on symptoms is also lacking in the medical literature. The purpose of this study is to find out:

1. the frequency of COPD patients demonstrating an appropriate use of inhalers that have flow-triggered systems,
2. whether the appropriate use of inhalers impacts the Quality of Life and Shortness of Breath of COPD patients, and
3. the impact of appropriate use of inhalers on FEV1 in COPD patients.

Conditions

Interventions

DIAGNOSTIC_TEST

In Check Dial test

In Check Dial test will test the ability to actuate the inhaler.

Sponsors & Collaborators

  • University of Alabama at Birmingham

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-09-25
Primary Completion
2022-08-09
Completion
2022-08-09
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04042168 on ClinicalTrials.gov